These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20978369)
1. The long and winding road to antibody therapeutics. McCafferty J MAbs; 2010; 2(5):459-60. PubMed ID: 20978369 [No Abstract] [Full Text] [Related]
2. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies. Malesci A; Angelucci E; Bonifacio C; Sociale O; Omodei P; Repici A; Balzarini L; Danese S Inflamm Bowel Dis; 2009 Jun; 15(6):814-5. PubMed ID: 18831523 [No Abstract] [Full Text] [Related]
3. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature. Jürgens M; Brand S; Filik L; Hübener C; Hasbargen U; Beigel F; Tillack C; Göke B; Ochsenkühn T; Seiderer J Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647 [No Abstract] [Full Text] [Related]
4. Adalimumab for cutaneous metastatic Crohn's disease. Cury DB; Moss AC; Elias G; Nakao A Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388 [No Abstract] [Full Text] [Related]
5. Tumor necrosis factor inhibitors: following best practice. White B Manag Care; 2005 May; 14(5 Suppl):17-23. PubMed ID: 15962833 [No Abstract] [Full Text] [Related]
6. Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications. Murdaca G; Colombo BM; Puppo F Drugs Today (Barc); 2011 Apr; 47(4):277-88. PubMed ID: 21573251 [TBL] [Abstract][Full Text] [Related]
7. Adalimumab for Mooren's ulcer. Cordero-Coma M; Benito MF; Fuertes CL; Antolín SC; García Ruíz JM Ophthalmology; 2009 Aug; 116(8):1589, 1589.e1. PubMed ID: 19651317 [No Abstract] [Full Text] [Related]